SCHEMBL7678396

SCHEMBL7678396

OCCN1CCN(Cc2ccnc(N3CCOCC3)c2)CC1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 3/20 0.48
▸ PKM P14618 1/20 0.46
▸ ALDH1A1 P00352 4/20 0.44
▸ KDM4E B2RXH2 3/20 0.44
▸ ABL1 P00519 2/20 0.43
▸ TBK1 Q9UHD2 3/20 0.42
▸ HCRTR1 O43613 1/20 0.41
▸ HCRTR2 O43614 1/20 0.41
▸ OPRM1 P35372 1/20 0.41
▸ OPRL1 P41146 1/20 0.41
▸ LRRK2 Q5S007 2/20 0.41
▸ HDAC1 Q13547 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ MPI P34949 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7681827 0.87 PIK3CA (0.47) PIK3CAALDH1A1KDM4EHCRTR1HCRTR2
SCHEMBL7673351 0.81 HRH3 (0.46) PIK3CAALDH1A1KDM4EOPRM1OPRL1
SCHEMBL3742630 0.81 PIK3CA (0.57) PIK3CAABL1LRRK2
SCHEMBL7673438 0.78 PIK3CA (0.46) PIK3CAALDH1A1TBK1HCRTR1HCRTR2
SCHEMBL7675387 0.76 PIK3CA (0.44) PIK3CAALDH1A1KDM4ETBK1HCRTR1
SCHEMBL8197483 0.75 PIK3CA (0.59) PIK3CAHCRTR1HCRTR2OPRM1OPRL1
SCHEMBL8358064 0.75 PIK3CA (0.54) PIK3CAABL1HCRTR1HCRTR2OPRM1
SCHEMBL5718308 0.75 PIK3CA (0.54) PIK3CAABL1HCRTR1HCRTR2OPRM1
SCHEMBL2459118 0.75 PIK3CA (0.54) PIK3CAABL1HCRTR1HCRTR2OPRM1
SCHEMBL7681152 0.74 CYP2D6 (0.55) PIK3CAALDH1A1KDM4ELMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6455520-B1 TUMOR NECROSIS FACTOR AND INTERLEUKIN INHIBITORS; ANTIINFLAMMATORY AGENTS, ANTIALLERGENS; BONE DISORDERS ASTRA ZENECA AB (SE) 2002-09-24 — — US disclosed
Send feedback